Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, January 23, 2012

An Energy Shot for the Brain -citicoline

I wrote about this earlier here:
http://oc1dean.blogspot.com/2011/10/introducing-ceraxon-first-only-oral.html
Now they're talking about more studies
http://online.wsj.com/article/SB10001424052970203806504577178970931093522.html
In some countries, citicoline is sold as a prescription drug to help regenerate the brain after a stroke. But efforts to gain Food and Drug Administration approval in U.S. were stymied when clinical trials found citicoline was no more effective than a placebo.

In October, citicoline hit the U.S. market in liquid form as a "medical food" called CerAxon for use in patients with stroke and traumatic brain injury. Medical foods don't require FDA approval but their labels must be truthful and they can be subject to a post-market review, the FDA says. CerAxon, which is sold by Ferrer Group of Barcelona, comes in two daily doses of 1,000 milligrams each. It doesn't require a prescription, but is intended to be used under a doctor's direction, Ferrer says.

Doctors say a study of more than 2,000 people funded by Ferrer—the largest ever on citicoline for stroke—may provide definitive evidence. The results will be announced in May, Ferrer says.

No comments:

Post a Comment